Skip to main content
Home

Main navigation

  • Home
  • Series
  • People
  • Depts & Colleges

Main navigation

  • Home
  • Series
  • People
  • Depts & Colleges

Universal Flu Vaccine

Series
Epidemics and Vaccines
Video Audio Embed
Dr Richard Antrobus talks about his research in the development of a universal flu vaccines.
Universal flu vaccines target specific parts of the influenza virus that stay relatively stable between different strains of flu. Dr Richard Antrobus is conducting a Phase I study for a universal influenza vaccine. Progress so far indicates that this approach induces a potent T cell response, and Dr Antrobus is assessing whether this response is equally potent in the elderly - one of the 'at risk' groups of the influenza virus. If successful this vaccine will protect against a wide range of strains of the virus.

More in this series

View Series
Epidemics and Vaccines

Viral vectored vaccine development

Professor Sarah Gilbert talks about her work on viral vectored vaccines.
Previous
Epidemics and Vaccines

Structural biology and vaccines

Structure of viruses
Next
Licence
Creative Commons Attribution-Non-Commercial-Share Alike 2.0 UK: England & Wales; http://creativecommons.org/licenses/by-nc-sa/2.0/uk/

Episode Information

Series
Epidemics and Vaccines
People
Richard Antrobus
Keywords
influenza
immunology
clinical trials
universal
flu
vaccines
Department: Nuffield Department of Clinical Medicine
Date Added: 26/06/2012
Duration: 00:06:37

Subscribe

Apple Podcast Audio Audio RSS Feed Video RSS Feed

Download

Download Video Download Audio

Footer

  • About
  • Accessibility
  • Contribute
  • Copyright
  • Contact
  • Privacy
'Oxford Podcasts' Twitter Account @oxfordpodcasts | MediaPub Publishing Portal for Oxford Podcast Contributors | Upcoming Talks in Oxford | © 2011-2022 The University of Oxford